10 Small Cap Stocks with Potential to Rise 1000 Percent
In this article, we look at 10 Small Cap Stocks with Potential to Rise 1000 Percent. Small-cap stocks have returned to the market’s risk conversation in 2026.
Allogene Therapeutics Inc. (ALLO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wildcat Capital Management Leonard A. Potter | 2,920,787 | $4,673,259 | 2.68% | |
| 2. | Bourgeon Capital John Zaro | 48,000 | $76,800 | +7% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.90 | 1,724,137 | $4,999,997.30 | 1,724,137 | 2024-05-16 | Filing | |
| $3.60 | 190 | $683.05 | 819,590 | 2024-01-30 | Filing | |
| $12.60 | 15,000 | $189,000.00 | 258,885 | 2022-01-12 | Filing | |
| $12.60 | 155,039 | $1,953,491.40 | 195,039 | 2022-01-12 | Filing | |
| $47.00 | 106,382 | $4,999,954.00 | 1,798,163 | 2020-06-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.34 | 36,342 | $48,698.28 | 1,045,877 | 2026-10-21 | Filing | |
| $2.12 | 29,697 | $62,957.64 | 488,267 | 2026-08-21 | Filing | |
| $2.31 | 9,586 | $22,143.66 | 124,517 | 2026-04-21 | Filing | |
| $2.50 | 2,867 | $7,167.50 | 195,338 | 2026-03-31 | Filing | |
| $2.47 | 4,835 | $11,942.45 | 198,205 | 2026-03-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,100,000 | $1,782,000 | 0.02% | |
| 2. | 1,039,328 | $1,662,925 | 0.05% | |
| 3. | 281,434 | $450,294 | 0.18% | |
| 4. | 279,259 | $446,815 | 0.01% | |
| 5. | 174,258 | $278,813 | 0% |
News See All
Investors' Stock Portfolio: Top 10 Penny Stocks To Buy
In this article, we will discuss Investors' Stock Portfolio: Top 10 Penny Stocks To Buy. Risk appetite, driven by artificial intelligence fervor, continues to drive sentiment in US equity markets.
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2026 Earnings Call Transcript
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2026 Earnings Call Transcript May 14, 2026 Operator: Hello. Thank you for standing by, and welcome to Therapeutics First Quarter 26 Conference Call.
9 Best Biotech Penny Stocks to Buy in 2026
In this article, we will discuss the 9 Best Biotech Penny Stocks to Buy in 2026.
10 Best Growth Stocks Under $10 to Invest In
In this article, we will discuss the 10 Best Growth Stocks Under $10 to Invest In.
10 Best Penny Stocks to Buy and Hold Under $5
In this article, we will look at the 10 Best Penny Stocks to Buy and Hold Under $5. Smaller companies have started to attract more attention on Wall Street.
10 Stocks Under $5 That Will Explode
In this piece, we will discuss the 10 Stocks Under $5 That Will Explode.
Piper Sandler Analysts Bullish on Allogene Therapeutics (ALLO) Ahead of Key ALPHA3 Data Readout
Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the 10 most active penny stocks to buy.
10 Most Active Penny Stocks to Buy
In this piece, we will discuss the 10 Most Active Penny Stocks to Buy.
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
Hedge Fund Resource Center